Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,672 | 362 | 97.2% |
| Education | $183.00 | 3 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62.59 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $732.92 | 30 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $686.81 | 25 | $0 (2024) |
| ABBVIE INC. | $655.66 | 24 | $0 (2024) |
| Biogen, Inc. | $584.41 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $479.74 | 26 | $0 (2024) |
| US WorldMeds, LLC | $399.75 | 20 | $0 (2020) |
| Lundbeck LLC | $327.51 | 22 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $324.44 | 9 | $0 (2024) |
| Lilly USA, LLC | $318.51 | 17 | $0 (2024) |
| Kyowa Kirin, Inc. | $303.35 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $696.35 | 30 | PFIZER INC. ($92.29) |
| 2023 | $809.70 | 40 | AbbVie Inc. ($159.27) |
| 2022 | $1,591 | 57 | ABBVIE INC. ($371.38) |
| 2021 | $1,165 | 45 | Amgen Inc. ($243.22) |
| 2020 | $997.21 | 37 | Neuronetics, Inc. ($225.26) |
| 2019 | $971.19 | 44 | Amgen Inc. ($180.83) |
| 2018 | $1,023 | 46 | Jazz Pharmaceuticals Inc. ($198.19) |
| 2017 | $1,664 | 69 | Teva Pharmaceuticals USA, Inc. ($329.46) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Central Nervous System | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Adenosine A2A Receptors | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Neurology | ||||||
| 07/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.68 | General |
| 07/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: PAIN | ||||||
| 07/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: AMANTADINE | ||||||
| 06/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 06/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Neurology | ||||||
| 05/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Rare Disease | ||||||
| 04/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.36 | General |
| 04/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PAIN | ||||||
| 03/21/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neurology | ||||||
| 03/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Neurology | ||||||
| 02/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: PAIN | ||||||
| 02/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 307 | 560 | $190,350 | $48,493 |
| 2022 | 4 | 319 | 588 | $157,108 | $44,793 |
| 2021 | 4 | 375 | 617 | $160,950 | $47,642 |
| 2020 | 4 | 457 | 837 | $225,495 | $55,973 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 223 | $66,900 | $19,452 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 207 | $41,400 | $12,568 | 30.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 24 | 66 | $24,024 | $4,884 | 20.3% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 11 | 11 | $10,890 | $3,466 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 25 | $10,000 | $3,083 | 30.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 16 | 16 | $31,136 | $3,029 | 9.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,000 | $2,012 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 262 | $78,600 | $22,847 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 256 | $51,200 | $15,602 | 30.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 20 | 47 | $17,108 | $3,333 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 23 | $10,200 | $3,011 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 250 | $75,000 | $23,066 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 177 | 294 | $58,695 | $18,032 | 30.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 46 | $23,000 | $6,034 | 26.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 27 | $4,255 | $509.46 | 12.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 189 | 427 | $127,895 | $31,502 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 209 | 348 | $69,600 | $16,819 | 24.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 32 | 32 | $16,000 | $4,567 | 28.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 27 | 30 | $12,000 | $3,085 | 25.7% |
About Dr. Ronald Stotz, MD
Dr. Ronald Stotz, MD is a Neurology healthcare provider based in Fredericksburg, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790721447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Stotz, MD has received a total of $8,917 in payments from pharmaceutical and medical device companies, with $696.35 received in 2024. These payments were reported across 368 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,672).
As a Medicare-enrolled provider, Stotz has provided services to 1,458 Medicare beneficiaries, totaling 2,602 services with total Medicare billing of $196,901. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Fredericksburg, TX
- Active Since 06/21/2006
- Last Updated 08/09/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790721447
Products in Payments
- Aimovig (Biological) $667.97
- UBRELVY (Drug) $447.12
- TYSABRI (Biological) $355.80
- AUSTEDO (Drug) $350.36
- EMGALITY (Drug) $253.22
- APTIOM (Drug) $247.76
- NEUROSTAR TMS THERAPY (Device) $244.42
- GOCOVRI (Drug) $224.41
- AIMOVIG (Biological) $221.68
- Xyrem (Drug) $209.40
- QULIPTA (Drug) $206.26
- NORTHERA (Drug) $206.14
- NOURIANZ (Drug) $205.04
- NURTEC ODT (Drug) $201.07
- APOKYN (Drug) $199.55
- VYVGART (Drug) $196.39
- ULTOMIRIS (Biological) $167.60
- KESIMPTA (Drug) $162.40
- OXTELLAR XR (Drug) $153.67
- ACTHAR (Biological) $151.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fredericksburg
Dr. Dale Pcsolyar, M.d, M.D
Neurology — Payments: $109,051
Barbara Decker, Md, MD
Neurology — Payments: $38,238
Sandra Crouse, Md, MD
Neurology — Payments: $11,893
Dr. Matthew Stotz, M.d, M.D
Neurology — Payments: $10,055
Theresa Weber, Md, MD
Neurology — Payments: $4,580
Dr. Richard Erwin, M.d, M.D
Neurology — Payments: $2,730